Progressive Corporation
PGR
$198.97
-1.79%
Progressive Corporation is a major US property and casualty insurer, primarily focused on underwriting private and commercial auto insurance, along with specialty lines and homeowners insurance. The company is a market leader in auto insurance, distinguished by its dual distribution model that leverages both independent agents and a highly efficient direct-to-consumer channel via internet and telephone. The current investor narrative centers on the resilience and strength of its core underwriting operations, as highlighted in recent analysis, while debate persists over whether its stock price fully reflects this fundamental strength or if it presents a value opportunity given its recent underperformance relative to the broader market.…
PGR
Progressive Corporation
$198.97
Related headlines
Investment Opinion: Should I buy PGR Today?
Rating & Thesis: Based on a synthesis of the data, Progressive Corporation (PGR) is a HOLD. The core thesis is that the stock presents a compelling value proposition based on fundamentals but requires a technical catalyst or evidence of margin sustainability to warrant a Buy rating, given its persistent downtrend and mixed sentiment.
Supporting Evidence: The Hold rating is supported by four key data points. First, valuation is compelling at an 11.81x trailing P/E and 1.52x P/S, which is reasonable for a company with its growth and ROE profile. Second, revenue growth remains robust at 12.19% YoY. Third, profitability is exceptional, with a net margin of 12.98% and ROE of 37.29%. Fourth, the balance sheet is pristine with minimal debt. However, these strengths are counterbalanced by the stock's -28.96% 1-year return and lack of positive price momentum.
Risks & Conditions: The two biggest risks to the thesis are 1) a further breakdown in technical support below $191.75, and 2) a cyclical compression of underwriting margins in upcoming quarters. This Hold would upgrade to a Buy if the stock establishes a clear technical base above its 52-week low and/or if Q1 2026 results demonstrate margin resilience. It would downgrade to a Sell if revenue growth decelerates below 8% or if the net margin contracts by more than 300 basis points sequentially. On valuation, the stock appears fairly valued to slightly undervalued relative to its own historical multiples but fairly valued relative to near-term cyclical risks.
Sign up to view all
PGR 12-Month Price Forecast
The AI assessment is Neutral with Medium confidence. Progressive is a fundamental powerhouse trapped in a bearish price trend. The quantitative case for value is strong, but the qualitative market narrative is overwhelmingly negative. The stock needs a catalyst—either a fundamental proof point that margins are sustainable or a technical reversal—to shift from a value trap to a value opportunity. The stance would upgrade to Bullish on a confirmed breakout above $230 with volume, or on a quarterly report showing sequential margin expansion. It would downgrade to Bearish on a confirmed break below $191.75 with a close beneath $190.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Progressive Corporation's 12-month outlook, with a consensus price target around $258.66 and implied upside of +30.0% versus the current price.
Average Target
$258.66
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$159 - $259
Analyst target range
Analyst coverage for Progressive is limited, with only 4 analysts providing estimates, which is unusually low for a company of its size and suggests it may be under-followed by the sell-side. The available data shows estimated EPS for the next period has a wide range from $13.78 to $19.95, with an average of $15.98, and estimated revenue averages $100.43 billion, but a consensus price target and explicit buy/hold/sell distribution are not available in the provided dataset. The wide dispersion in EPS estimates signals high uncertainty among the few covering analysts regarding the company's near-term earnings trajectory; without a clear consensus target price, it is challenging to gauge institutional sentiment, though recent institutional ratings from firms like Morgan Stanley (Underweight) and B of A Securities (Buy) indicate a lack of unanimity, and the limited coverage itself can contribute to higher volatility and less efficient price discovery for the stock.
Bulls vs Bears: PGR Investment Factors
The investment debate for Progressive centers on a stark disconnect between deteriorating price action and resilient fundamentals. The bear case, led by severe technical underperformance and cyclical concerns, currently holds stronger evidence in the market's pricing. However, the bull case is grounded in exceptionally strong financials—12.19% revenue growth, a 37.29% ROE, and fortress-like cash flow—that appear deeply discounted at an 11.81x P/E. The single most important tension is whether the market is correctly anticipating a cyclical downturn in underwriting profitability or is mispricing a high-quality compounder experiencing a temporary sentiment-driven sell-off. The resolution of this tension hinges on the sustainability of its industry-leading margins in the coming quarters.
Bullish
- Exceptional Underwriting Profitability & ROE: Progressive's Q4 2025 net margin of 12.98% and a trailing ROE of 37.29% demonstrate superior operational efficiency and capital allocation. This profitability, driven by a disciplined underwriting machine, is a key competitive advantage in the P&C insurance sector.
- Strong Revenue Growth Trajectory: The company delivered 12.19% YoY revenue growth in Q4 2025, with quarterly revenue consistently rising from $20.40B to $22.74B throughout the year. This accelerating top-line trajectory, primarily from its massive Personal Lines segment, indicates robust demand and effective market share capture.
- Rock-Solid Balance Sheet & Cash Flow: With a minimal debt-to-equity ratio of 0.227 and TTM free cash flow of $17.20 billion, Progressive is financially fortress-like. This strong cash generation provides ample flexibility for growth investments, share buybacks, and dividends without financial strain.
- Deep Valuation Discount to History: At a trailing P/E of 11.81x, the stock trades near the lower end of its historical range, which has seen multiples over 50x. This represents a significant compression relative to its own earnings power, potentially pricing in excessive pessimism given its stable fundamentals.
Bearish
- Severe Technical Downtrend & Underperformance: PGR has declined 28.96% over the past year, drastically underperforming the S&P 500's 25.19% gain. Trading at only 27.6% of its 52-week range ($191.75-$289.96), the chart shows a clear downtrend with no reversal signal, risking further declines.
- Limited Analyst Coverage & High Uncertainty: With only 4 covering analysts, the stock is under-followed, contributing to potential price inefficiency and volatility. The wide EPS estimate range ($13.78-$19.95) signals high uncertainty about near-term earnings, and the lack of a consensus price target muddies the valuation picture.
- Vulnerable to Cyclical Margin Peaks: The P&C insurance industry is cyclical, and Progressive's current net margin of 12.98% and ROE of 37.29% may represent peak profitability. A normalization of underwriting results or an increase in claims severity could compress these industry-leading margins.
- Unreliable Dividend for Income Investors: Despite a 2.15% dividend yield, recent analysis highlights it as unreliable for income-focused investors. The low payout ratio of 25.4% suggests capacity, but the primary total return thesis does not rest on income, limiting its appeal to a key investor base.
PGR Technical Analysis
The stock is in a pronounced downtrend, having declined 28.96% over the past year, significantly underperforming the S&P 500's 25.19% gain. With a current price of $199.73, it is trading at only 27.6% of its 52-week range ($191.75 to $289.96), positioning it much closer to its 52-week low than its high, which suggests the market is pricing in significant pessimism and could indicate a deep value opportunity, though it also risks being a 'falling knife' if fundamentals deteriorate further. Recent short-term momentum shows continued weakness, with the stock down 0.75% over the past month and 2.35% over the past three months, a deceleration from the steeper 6-month decline of 11.30% but still in negative territory, indicating the downtrend persists without a clear reversal signal. The stock exhibits low market correlation with a beta of 0.295, meaning it is roughly 70% less volatile than the broader market, which is unusual for a financial stock and may reflect its defensive characteristics or specific company-related risks; key technical levels to watch are the 52-week low of $191.75 as critical support, a breakdown below which could trigger further selling, and the 52-week high of $289.96 representing a distant resistance level that would require a major positive catalyst to approach.
Beta
0.29
0.29x market volatility
Max Drawdown
-33.0%
Largest decline past year
52-Week Range
$192-$290
Price range past year
Annual Return
-29.2%
Cumulative gain past year
| Period | PGR Return | S&P 500 |
|---|---|---|
| 1m | -4.1% | +5.5% |
| 3m | -2.5% | +7.7% |
| 6m | -12.3% | +12.7% |
| 1y | -29.2% | +27.4% |
| ytd | -6.2% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PGR Fundamental Analysis
Revenue growth remains robust, with Q4 2025 revenue of $22.74 billion representing a 12.19% year-over-year increase, and the sequential trend from Q1 to Q4 2025 shows consistent quarterly revenue growth from $20.40 billion to $22.74 billion, indicating a healthy and accelerating top-line trajectory primarily driven by its massive Personal Lines Segment, which generated $18.71 billion in the latest period. Profitability is strong, with the company reporting net income of $2.95 billion in Q4 2025 and a net margin of 12.98%, while gross margin for the quarter was a healthy 29.28%; examining the quarterly progression, net income has grown from $2.57 billion in Q1 to $2.95 billion in Q4, and the gross margin has remained stable in the high-20% to low-30% range, demonstrating disciplined underwriting and operational efficiency. The balance sheet is exceptionally healthy, evidenced by a very low debt-to-equity ratio of 0.227, a strong return on equity of 37.29%, and robust free cash flow generation with a TTM figure of $17.20 billion, indicating the company generates ample internal cash to fund operations, growth, and shareholder returns without relying on excessive leverage.
Quarterly Revenue
$22.7B
2025-12
Revenue YoY Growth
+0.12%
YoY Comparison
Gross Margin
+0.29%
Latest Quarter
Free Cash Flow
$17.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PGR Overvalued?
Given the company's substantial net income, the primary valuation metric is the P/E ratio. The trailing P/E stands at 11.81x, while the forward P/E is slightly higher at 12.34x; the minimal gap suggests the market expects relatively stable, rather than accelerating, earnings growth in the near term. Compared to sector averages, Progressive's valuation presents a mixed picture: its trailing P/E of 11.81x is below the typical range for high-quality insurers, and its Price-to-Sales ratio of 1.52x and EV-to-Sales of 1.36x appear reasonable, potentially indicating a discount relative to its growth and profitability profile, especially its industry-leading ROE of 37.29%. Historically, the stock's current trailing P/E of 11.81x is near the lower end of its own historical range observed in recent quarters, which has seen P/E ratios fluctuate from the low teens to over 50x during periods of earnings volatility; this positioning near historical lows suggests the market may be undervaluing the company's consistent earnings power, or it may reflect concerns about peak cyclical margins in the P&C insurance industry.
PE
11.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -31x~137x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Progressive's primary financial risk is not leverage or liquidity—its 0.23 debt-to-equity and $17.2B FCF are strengths—but rather the cyclicality of its core profitability. The company's stellar 12.98% net margin and 37.29% ROE are likely at or near a cyclical peak for the P&C industry. A reversion to the mean, driven by increased claims frequency/severity or competitive pricing pressure, could significantly compress earnings. Revenue concentration in auto insurance (Personal Lines generated $18.71B last quarter) also exposes it to regulatory changes, technological disruption (e.g., autonomous vehicles long-term), and macroeconomic sensitivity to driving trends.
Market & Competitive Risks: The stock's 28.96% annual decline and low 0.295 beta indicate it is facing severe, company-specific de-rating rather than broad market weakness. The key market risk is continued valuation compression; its 11.81x trailing P/E, while low historically, could fall further if the market re-categorizes it as a low-growth financial rather than a growth compounder. Competitive risks are high in the commoditized auto insurance space, where price competition is fierce and new digital entrants could pressure margins. The stock's low beta may also work against it in a sustained bull market, causing it to be overlooked in a sector rotation towards high-beta names.
Worst-Case Scenario: The worst-case scenario involves a perfect storm of cyclical downturn and sustained negative sentiment. This would entail a significant miss on the low-end EPS estimate ($13.78), a breakdown of underwriting discipline leading to margin collapse, and continued institutional selling. In this adverse scenario, the stock could realistically test and break its 52-week low of $191.75, representing a -4.0% decline from the current $199.73. A more severe bear case, aligning with the stock's maximum drawdown of -33.03%, could see it fall to the $160-$170 range, implying a potential loss of -15% to -20% from current levels, especially if the broader market also corrects.
FAQ
The key risks are, in order of severity: 1) Cyclical & Profitability Risk: The core risk is a downturn in the insurance underwriting cycle compressing its industry-leading 12.98% net margin. 2) Technical & Sentiment Risk: The stock is in a pronounced downtrend, down 28.96% in a year, and breaking below $191.75 support could trigger further selling. 3) Analyst & Visibility Risk: With only 4 covering analysts and a wide EPS estimate range ($13.78-$19.95), there is high uncertainty and potential for negative surprises. 4) Competitive Risk: The auto insurance market is highly competitive, which could pressure pricing and market share over time.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $210 and $240, as steady execution is offset by a lack of positive catalysts. The Bull Case (30% probability) targets $260-$290, requiring a market re-rating on sustained margin strength. The Bear Case (20% probability) warns of a drop to $175-$195 if profitability deteriorates and technical support fails. The Base Case is most likely, assuming a moderate normalization of the insurance cycle. The wide forecast range reflects the high uncertainty from limited analyst coverage.
PGR appears fairly valued to slightly undervalued based on a blended assessment. Its trailing P/E of 11.81x and Price/Sales of 1.52x are at the low end of its historical range and reasonable for a financial stock, especially one with its 12.19% revenue growth. Compared to its own exceptional fundamentals like a 37.29% ROE, the valuation seems cheap. However, the market is likely applying a discount due to cyclical concerns about peak margins in the P&C insurance industry. The valuation implies the market expects earnings growth to stagnate or decline, not accelerate.
PGR is a good buy for a specific type of investor: a patient value seeker comfortable with contrarian positions. The stock offers a compelling 37.29% ROE at a discounted 11.81x P/E, with a fortress balance sheet (0.23 D/E). However, it is in a severe downtrend, down 28.96% over the past year, and lacks positive momentum. The biggest downside risk is a breakdown below the $191.75 support level. Therefore, it is a good buy for those building a long-term position in stages, but not for short-term traders or those requiring immediate price appreciation.
PGR is unequivocally suitable for a long-term investment horizon, with a suggested minimum holding period of 3-5 years. Its low beta (0.295) and lack of momentum make it a poor candidate for short-term trading. The investment thesis is based on the company's durable competitive advantages in underwriting and its capital return potential, which will take time to be reflected in the stock price after the current negative sentiment cycle. Long-term investors can benefit from compounding intrinsic value growth and potential multiple expansion, while collecting a modest 2.15% dividend yield. Short-term traders would be fighting a clear downtrend.